Growth Metrics

Idexx Laboratories (IDXX) Non-Current Deferred Tax Liability (2016 - 2026)

Idexx Laboratories has reported Non-Current Deferred Tax Liability over the past 17 years, most recently at $153.8 million for Q4 2025.

  • For Q4 2025, Non-Current Deferred Tax Liability rose 1259.21% year-over-year to $153.8 million; the TTM value through Dec 2025 reached $153.8 million, up 1259.21%, while the annual FY2025 figure was $153.8 million, 1259.21% up from the prior year.
  • Non-Current Deferred Tax Liability for Q4 2025 was $153.8 million at Idexx Laboratories, up from $3.7 million in the prior quarter.
  • Over five years, Non-Current Deferred Tax Liability peaked at $153.8 million in Q4 2025 and troughed at $2.1 million in Q2 2025.
  • A 5-year average of $21.1 million and a median of $9.5 million in 2021 define the central range for Non-Current Deferred Tax Liability.
  • Biggest five-year swings in Non-Current Deferred Tax Liability: plummeted 92.57% in 2023 and later surged 1259.21% in 2025.
  • Year by year, Non-Current Deferred Tax Liability stood at $8.9 million in 2021, then skyrocketed by 989.49% to $97.3 million in 2022, then plummeted by 92.57% to $7.2 million in 2023, then skyrocketed by 56.35% to $11.3 million in 2024, then surged by 1259.21% to $153.8 million in 2025.
  • Business Quant data shows Non-Current Deferred Tax Liability for IDXX at $153.8 million in Q4 2025, $3.7 million in Q3 2025, and $2.1 million in Q2 2025.